日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.

SARS-CoV-2 刺突糖蛋白编码的改良型自扩增核糖核酸 (saRNA) 疫苗在 SARS-CoV-2 血清阴性和血清阳性乌干达个体中的安全性和免疫原性

Kitonsa Jonathan, Serwanga Jennifer, Cheeseman Hannah M, Abaasa Andrew, Lunkuse Jane Frances, Ruzagira Eugene, Kato Laban, Nambaziira Florence, Oluka Gerald Kevin, Gombe Ben, Jackson Sembera, Ssebwana Joseph Katende, McFarlane Leon R, Joseph Sarah, Pierce Benjamin F, Shattock Robin J, Kaleebu Pontiano

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa

HIV-CORE 006 研究:在东非和南部非洲健康成年人中开展的一项双盲、随机、安慰剂对照的 1 期临床试验,评估了由 ChAdOx1 和 MVA 载体递送的 HIVconsvX 保守嵌合候选 T 细胞疫苗的安全性和广泛免疫原性。

Chanda, Chama; Kibengo, Freddie; Mutua, Michael; Ogada, Fred; Muturi-Kioi, Vincent; Akis Yildirim, Belkis M; Amondi, Mary; Baines, Andrea; Basajja, Vincent; Borthwick, Nicola; Bosire, Kefa; Chambula, Elias; Chetty, Paramesh; Chinyenze, Kundai; Chirro, Oscar; Crook, Alison; De Bont, Jan; Fernandez, Natalia; Ejou, Peter; Farah, Bashir; Glaze, Molly; Gombe, Ben; Gumbe, Anne; Hayes, Peter; Itwi, Sally; Juma, Sheba; Kabarambi, Anita; Kabengele, Chishiba; Kafeero, Paddy; Kakande, Ayoub; Kanungi, Jennifer; Kidega, William; King, Deborah; Mahira, Rose; Malogo, Roselyn; Matsoso, Mabela; Michelo, Clive; Moyo, Annie; Mugaba, Susan; Mugenya, Irene; Muhumuza, Patrick; Mujadidi, Yama F; Muriuki, Moses; Musale, Vernon; Mutua, Gaudensia; Muwowo, Meya; Mwale, Fatima; Mwangi, Irene; Nakimbugwe, Maria; Namuyanja, Angella; Nduati, Eunice; Nielsen, Leslie; Nyange, Jaquelyn; Oino, Geofrey; Okech, Brenda; Omosa-Manyonyi, Gloria; Otieno, Dan; Palmer, Shaun; Phiri, Hilda; Ramko, Kelly; Rutishauser, Rachel L; Sayeed, Eddy; Sajabi, Rose; Serwanga, Jennifer; G-T Wee, Edmund; Wenden, Claire; Cicconi, Paola; Fast, Patricia; Gilmour, Jill; Jaoko, Walter; Kaleebu, Pontiano; Kilembe, William; Kuipers, Hester; Sanders, Eduard J; Hanke, Tomáš

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles

在乌干达不同基线免疫特征的人群中,均观察到对牛津-阿斯利康(ChAdOx1-S,Covishield)SARS-CoV-2疫苗ChAdOx1-S的持续且强效的抗体反应。

Serwanga, Jennifer; Oluka, Gerald Kevin; Baine, Claire; Ankunda, Violet; Sembera, Jackson; Kato, Laban; Katende, Joseph Ssebwana; Odoch, Geoffrey; Auma, Betty Oliver; Gombe, Ben; Musenero, Monica; Kaleebu, Pontiano

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

乌干达既往感染过轻症或无症状新冠肺炎患者接种阿斯利康疫苗后抗体反应的血清阳性率和持久性:对疫苗政策的启示

Serwanga, Jennifer; Baine, Claire; Mugaba, Susan; Ankunda, Violet; Auma, Betty Oliver; Oluka, Gerald Kevin; Kato, Laban; Kitabye, Isaac; Sembera, Jackson; Odoch, Geoffrey; Ejou, Peter; Nalumansi, Amina; Gombe, Ben; Musenero, Monica; Kaleebu, Pontiano

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.

在乌干达优化和验证常规 ELISA 以及检测和定量抗 SARS-CoV-2 刺突蛋白、RBD 和核蛋白 IgG、IgM 和 IgA 抗体的临界值

Oluka Gerald Kevin, Namubiru Patricia, Kato Laban, Ankunda Violet, Gombe Ben, Cotten Matthew, Musenero Monica, Kaleebu Pontiano, Fox Julie, Serwanga Jennifer

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.

疫情前,乌干达样本中 SARS-CoV-2 特异性 IFN-γ 和抗体反应较低,HIV 阳性样本中则显著降低

Nantambi Hellen, Sembera Jackson, Ankunda Violet, Ssali Ivan, Kalyebi Arthur Watelo, Oluka Gerald Kevin, Kato Laban, Ubaldo Bahemuka, Kibengo Freddie, Katende Joseph Ssebwana, Gombe Ben, Baine Claire, Odoch Geoffrey, Mugaba Susan, Sande Obondo James, Kaleebu Pontiano, Serwanga Jennifer

A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences

在乌干达开展的一项针对SARS-CoV-2血清阴性和血清阳性人群的I期新冠疫苗试验,采用自扩增RNA疫苗平台:筛选和入组经验

Kitonsa, Jonathan; Kamacooko, Onesmus; Ruzagira, Eugene; Nambaziira, Florence; Abaasa, Andrew; Serwanga, Jennifer; Gombe, Ben; Lunkuse, Jane; Naluyinda, Hadijah; Tukamwesiga, Naboth; Namata, Tamara; Kigozi, Antony; Kafeero, Paddy; Basajja, Vincent; Joseph, Sarah; Pierce, Benjamin F; Shattock, Robin; Kaleebu, Pontiano

Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.

优化和验证用于测定 CN54gp140 和 AIDSVAX BE 抗体反应的 ELISA 检测方法,以用于 IIb 期 PrEPVacc 疫苗试验

Gombe Ben, Streatfield Claire, Leal Lorna, Opio Solomon, Joseph Sarah, Weber Jonathan, Hare Jonathan, Kaleebu Pontiano, Serwanga Jennifer